LYNKEUS BIOTECH

Chemicals, namely, biochemical and molecular biological products for use in manufacture of pharmaceutical and veterinary pharmaceutical preparations for the diagnosis and therapy of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases; chemicals, namely, biochemical products and molecular biological products in the nature of nucleic acid probes and antibodies for the detection of degenerative diseases of the central nervous system, the eye, vasculature, and for the detection of autoimmune diseases for scientific use

Pharmaceutical preparations for use in the treatment of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases; veterinary pharmaceutical preparations for use in the treatment of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases in domestic pets, live-stock, poultry, amphibians, teleosts and insects; preparations for healthcare, namely, dietetic products for medical purposes in the nature of dietary supplements, diet pills, dietary drink mix for use as a meal replacement, dietary food supplements, food for medically restricted diets, and meal replacement bars

Educational services, namely, conducting seminars, lectures, academies, colloquiums, conferences, congresses, symposiums, workshops, practical training, in the field of molecular biology, genetic engineering, and molecular diagnostics

Scientific research; technical research in the field of chemistry, biology and diagnosis of neuronal, especially opthalmological indications like retinal degradations and of diseases related to defects in vasculature or diseases related to vasculature and of autoimmune diseases; scientific research in the field of gene therapy; laboratory research in the field of molecular biology, animal models and cell culture systems; chemist services, biochemist services; technical consultation and research in the fields of biology; mission oriented research and diagnostics, namely, diagnostic services in the field of diagnostic services in the field of diseases of the eye, diseases related to defects in vasculature, and autoimmune diseases and genetic, biochemical, and medical research; chemical and biochemical laboratories; genealogy research in the nature of generating of gene therapy-protocols; computer software development for data processing; consultation in the fields of molecular biology, genetic engineering, molecular diagnostics, gene therapy, and molecular medicine; research in the field of gene therapy and molecular medicine